Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „continued“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · 18 peripheral neuropathy was 8 weeks. Patients who discontinued due to peripheral neuropathy received a median
Eintrag öffnenAmgevita · 4.8 · The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlle
Eintrag öffnenAmgevita · 4.8 · The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlle
Eintrag öffnenAmsparity · 4.8 · The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlle
Eintrag öffnenAmsparity · 4.8 · The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlle
Eintrag öffnenAmsparity · 4.8 · The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlle
Eintrag öffnenApretude · 4.8 · In HPTN 084, no participants discontinued cabotegravir because of ISRs. Out of 13068 injections, 1171 ISRs wer
Eintrag öffnenApretude · 4.8 · Local injection site reactions (ISRs) In HPTN 083, 2% of participants discontinued cabotegravir because of ISR
Eintrag öffnenBaraclude · 4.8 · 8 In the clinical trials entecavir treatment was discontinued if patients achieved a prespecified response. If
Eintrag öffnenBaraclude · 4.8 · In the clinical trials entecavir treatment was discontinued if patients achieved a prespecified response. If t
Eintrag öffnenBaraclude · 4.8 · Treatment beyond 48 weeks: continued treatment with entecavir for a median duration of 96 weeks did not reveal
Eintrag öffnenBaraclude · 4.8 · Treatment beyond 48 weeks: continued treatment with entecavir for a median duration of 96 weeks did not reveal
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.1% (2/2 082) of patients due to Type 1 diabetes mellitus. Type 1 diabetes melli
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.1% (2/2 082) of patients due to immune-mediated adrenal insufficiency. All 11 p
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.2% (1/489) of patients due to Type 1 diabetes mellitus. All 5 patients with Typ
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.2% (1/489) of patients due to immune-mediated thyroid disorders. Thyroid disord
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.2% (4/2 082) of patients due to immune-mediated nephritis. All 7 patients with
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.2% (4/2 082) of patients due to immune-mediated thyroid disorders. Thyroid diso
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.4% (2/489) of patients due to immune-mediated colitis. All 13 patients with imm
Eintrag öffnenBavencio · 4.8 · Avelumab was discontinued in 0.4% (9/2 082) of patients due to immune-mediated pneumonitis. All 28 patients wi
Eintrag öffnen